Lv42
488 积分 2025-07-29 加入
Lymph node environment drives FSP1 targetability in metastasizing melanoma
17小时前
已完结
Error bars in experimental biology
22小时前
已完结
Differences of Clinical and Laboratory Features between Dipeptidyl Peptidase-4 Inhibitor-Related and Non-Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: A systematic review and meta-analysis
2天前
已完结
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020
2天前
已完结
Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study
2天前
已完结
Characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated pemphigus patients: A retrospective analysis of 66 cases
3天前
已完结
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors
3天前
已完结
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids
3天前
已完结
Association Between Medication Use and Bullous Pemphigoid
3天前
已完结
Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
3天前
已完结
皖公网安备34019202002308
